ImClone Systems Incorporated
Overview
ImClone Systems Incorporated is a biopharmaceutical company that focuses on developing treatments for cancer. It is a subsidiary of Eli Lilly and Company.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ImClone Systems Incorporated in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.